CIMINO, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 9.343
EU - Europa 5.882
AS - Asia 2.913
SA - Sud America 204
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 13
Totale 18.419
Nazione #
US - Stati Uniti d'America 9.273
NL - Olanda 1.919
CN - Cina 1.607
GB - Regno Unito 1.293
UA - Ucraina 745
SG - Singapore 732
SE - Svezia 490
FI - Finlandia 319
DE - Germania 313
RU - Federazione Russa 291
TR - Turchia 243
IT - Italia 185
BR - Brasile 157
FR - Francia 116
IE - Irlanda 106
VN - Vietnam 89
IN - India 48
BD - Bangladesh 39
CA - Canada 37
BE - Belgio 34
HK - Hong Kong 30
JP - Giappone 29
KR - Corea 25
MX - Messico 24
ES - Italia 17
EU - Europa 15
AR - Argentina 14
TG - Togo 14
PL - Polonia 13
KE - Kenya 12
AU - Australia 11
RO - Romania 11
ZA - Sudafrica 11
IQ - Iraq 9
IR - Iran 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 5
CO - Colombia 5
EC - Ecuador 5
LT - Lituania 5
VE - Venezuela 5
BO - Bolivia 4
ID - Indonesia 4
PE - Perù 4
PK - Pakistan 4
PY - Paraguay 4
UZ - Uzbekistan 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
CL - Cile 3
JM - Giamaica 3
LU - Lussemburgo 3
MA - Marocco 3
NP - Nepal 3
SI - Slovenia 3
TN - Tunisia 3
AT - Austria 2
BZ - Belize 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IM - Isola di Man 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
Totale 18.419
Città #
Amsterdam 1.912
Dallas 1.185
Southend 1.113
Woodbridge 1.095
Fairfield 951
Houston 702
Ashburn 645
Jacksonville 610
Ann Arbor 609
Chandler 413
Seattle 389
Cambridge 379
Singapore 373
San Jose 359
Nanjing 337
Wilmington 334
Beijing 232
Izmir 186
Boardman 145
Helsinki 126
Nanchang 111
Dublin 106
San Mateo 90
New York 88
Princeton 87
Lauterbourg 80
Bremen 77
Shenyang 77
Hebei 73
Tianjin 66
Los Angeles 61
Changsha 56
Mülheim 52
Council Bluffs 47
Jiaxing 45
Moscow 44
Buffalo 41
San Diego 40
Kunming 38
Santa Clara 38
Brussels 34
Jinan 34
Shanghai 34
Munich 33
Ho Chi Minh City 32
Düsseldorf 28
Istanbul 27
Hanoi 25
Velikiy Novgorod 25
Des Moines 24
Hangzhou 24
Seongnam 24
The Dalles 24
Dearborn 20
Guangzhou 20
San Francisco 20
Turku 20
Hong Kong 19
Orem 18
London 16
Orange 16
São Paulo 16
Lanzhou 15
Toronto 15
Kocaeli 14
Lomé 14
Chennai 13
Denver 13
Taizhou 13
Montreal 12
Ningbo 12
Shenzhen 12
Changchun 11
Chicago 11
Frankfurt am Main 11
Tokyo 11
Warsaw 11
Milan 10
Wuppertal 10
Brooklyn 9
Haikou 9
Querétaro 9
Venice 9
Atlanta 8
Manchester 8
Mumbai 8
Nairobi 8
West Jordan 8
Zhengzhou 8
Auburn Hills 7
Ankara 6
Fuzhou 6
Johannesburg 6
Mexico City 6
Norwalk 6
Nuremberg 6
Poplar 6
Rio de Janeiro 6
St Petersburg 6
Boston 5
Totale 14.303
Nome #
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 3.185
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 433
Extended role of necrotic cell death after hypoxia-ischemia-induced neurodegeneration in the neonatal rat 311
Microencephalic rats as a model for cognitive disorders. 283
New therapeutic strategies in perinatal stroke 258
CHRONIC CAFFEINE TREATMENT AND ADENOSINE RECEPTORS 252
AUTORADIOGRAPHIC LOCALIZATION OF [3H]THIOCOLCHICOSIDE BINDING SITES IN THE RAT BRAIN AND SPINAL CORD 248
Biochemical effects of minaprine on striatal dopaminergic neurons in rats. 248
MICROENCEPHALIC RATS AS A MODEL FOR COGNITIVE DISORDERS 246
Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia-ischemia in the newborn rat 242
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 241
Treatment with LXR agonists after focal cerebral ischemia prevents brain damage. 236
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. 234
Characteristics of the binding of phenoxybenzamine to calmodulin. 232
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4 228
2-(SUBSTITUTED)AMINO-2,8-DIAZASPIRO[4,5]DECAN-1,3-DIONES AS POTENTIAL MUSCARINIC AGONISTS: SYNTHESIS, MODELING AND BINDING STUDIES 220
Anatomical localization of calmodulin mRNA in the rat brain with cloned cDNA and synthetic oligonucleotide probes. 217
Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage 210
Triflusal reduces cerebral ischemia induced inflammation in a combined mouse model of Alzheimer's disease and stroke 210
In vivo modulation of striatal phosphoproteins by dopaminergic agents. 208
In situ hybridization histochemistry as a tool to study gene expression and its regulation in the central nervous system. 207
The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. 200
Protein phosphorylation in rat pineal gland and its regulation in supersensitive and subsensitive states. 196
SIMVASTATIN PROTECTS AGAINST THE LONG-LASTING BEHAVIORAL AND MORPHOLOGICAL CONSEQUENCES OF A NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY 194
Preclinical randomized controlled multicenter trials (pRCT) in stroke research: a new and valid approach to improve translation? 194
Differential ontogenetic expression and regulation of proenkephalin and preprosomatostatin mRNAs in rat caudate-putamen as studied by in situ hybridization histochemistry. 193
Chronic uridine treatment reduces the level of [3H]spiperone-labelled dopamine receptors and enhances their turnover rate in striatum of young rats: relationship to dopamine-dependent behaviours. 192
Ventral tegmental area/substantia nigra and prefrontal cortex rodent organotypic brain slices as an integrated model to study the cellular changes induced by oxygen/glucose deprivation and reperfusion: Effect of neuroprotective agents 191
Study on some compensatory responses of dopaminergic system in aging rats. 190
The hard way to acute stroke treatment. 189
3-Demetoxy-3-glycosylaminothiocolchicines: synthesis of a new class of putative muscle relaxant compounds. 188
Interaction of nerve growth factor with tubulin. Studies on binding and induced polymerization. 187
Neuroprotective Effect of Simvastatin in Stroke: A Comparison Between Adult and Neonatal Rat Models of Cerebral Ischemia 185
SELECTIVE ALTERATION IN B-50 (GAP-43) PHOSPHORYLATION IN BRAIN AREAS OF ANIMALS CHARACTERIZED BY COGNITIVE IMPAIRMENT 184
Cellular expression of somatostatin in MAM-induced Microencephaly in the rat 184
Differential effect of ganglioside GM1 on rat brain phosphoproteins: potentiation and inhibition of protein phosphorylation regulated by calcium/calmodulin and calcium/phospholipid-dependent protein kinases. 183
Ontogenetic development of calmodulin mRNA in rat brain using in situ hybridization histochemistry. 182
Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor 181
Developmentally regulated expression of calcitonin gene-related peptide at mammalian neuromuscular junction. 180
Differential translocation of protein kinase C isozymes in rats characterized by a chronic lack of LTP induction and cognitive impairment 180
Expression of hexokinase mRNA in human hippocampus 177
Distribution of nicotinic receptors in cynomolgus monkey brain and ganglia: localization of α3 subunit mRNA, α-bungarotoxin and nicotine binding sites 177
Quantitative autoradiography of central neurotransmitter receptors: methodological and statistical aspects with special reference to computer-assisted image analysis. 175
Pharmacological regulation of calmodulin. 174
Methylazoxymethanol-induced microencephaly: persistent increase of cortical somatostatin-like immunoreactivity. 174
Characterization of [3H]thiocolchicoside binding sites in rat spinal cord and cerebral cortex 173
Studies on binding of GTP to the microtubule protein. 173
Dopaminergic effects of buspirone, a novel anxiolytic agent. 172
GPR17 expressing NG2-Glia: Oligodendrocyte progenitors serving as a reserve pool after injury 172
Statins: multiple mechanisms of action in the ischemic brain 171
Acute and chronic effects of psychoactive drugs on adrenergic receptors and calmodulin. 163
Effects of ganglioside GM1 treatment on striatal glucose metabolism, blood flow, and protein phosphorylation of the rat. 159
Localization and age-dependent expression of hexokinase mRNA in the rat brain 159
[3H]-CGP 39653 mapping of glutamatergic N-methyl-D-aspartate receptors in the brain of aged rats. Neurosci. Res. Commun. 12, 31-40, 1993. 158
Identification and functional significance of nicotinic cholinergic receptors in the rat pineal gland 158
Long-lasting behavioral alterations following an hypoxic/ischemic brain injury in neonatal rats 158
Novel 3-O-glycosyl-3-demethylthiocolchicines as ligands for glycine and gamma-aminobutyric acid receptors. 157
Decrease in mRNA levels but not in the density of D2 dopamine receptors in rat striatum after transient forebrain ischemia. 156
Changes in Protein Kinase C and its presynaptic substrate B-50/GAP-43 after intrauterine exposure to methylazoxymethanol, a treatment inducing cortical and hippocampal damage and cognitive impairments 156
Microencephaly reduces the phosphorylation of the PKC substrate B-50/GAP43 in rat cortex and hippocampus. 155
INTERACTION OF SOME 2-HYDROXYBENZYLPIPERIDINES WITH DOPAMINE RECEPTORS 151
Multiexponential T2-relaxation analysis in cerebrally damaged rats in the absence and presence of a gadolinium contrast agent. 151
CaMKII-dependent phosphorylation of NR2A and NR2B is decreased in animals characterized by hippocampal damage and impaired LTP. Eur. J. Neurosci. 11, 141-148, 1999. 150
Synthesis of a new series of 2,8-disubstituted-2,8-diazaspiro[4,5]decan-1-ones as a potential muscarinic agonists 148
New insights into brain damage in stroke-prone rats: a nuclear magnetic imaging study 145
Age-related modification of dopaminergic and beta-Adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S-adenosylmethionine. 145
Levels of NGF, p75NGFR and ChAT immunoreactivity in brain of adult and aged microencephalic rats 144
Morphometrical and microdensitometrical studies on peptide- and tyrosine hydroxylase-like immunoreactivities in the forebrain of rats prenatally exposed to methylazoxymethanol acetate. 142
Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives. 141
Calcium/calmodulin-dependent protein kinase II is associated to NR2A/B subunits of NMDA receptor in post synaptic densities. J. Neurochem. 71,1733-1741,1998. 139
Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and morphological consequences of neonatal hypoxic-ischemic brain injury, reduces interleukin-1beta and tumor necrosis factor-alpha mRNA induction, and does not affect endothelial nitric oxide synthase expression 138
Photoaffinity labeling of calmodulin byphenothiazine antipsychotics. 135
Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats. 129
Effects of sustained hyperprolactinemia induced by chronic treatment with domperidone on central dopaminergic systems in the rat. 127
Activation of NK-kB and ERK 1/2 after permanent focal ischemia is abolished by simvastatin treatment. 126
Cyclic nucleotide- and calcium-dependent protein phosphorylation in rat pineal gland: physiological and pharmacological regulation. 122
Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons. 118
In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-DOPA. 117
The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation. 116
1-Aminocylopropane-1-carboxylic acid derivatives as ligands at the glycine-binding site of the N-methyl-D-aspartate receptor 112
EFFECTS OF POSTNATAL OR ADULT CHRONIC ACETYLCHOLINESTARASE INHIBITION ON MUSCARINIC RECEPTORS, PHOSPHOINOSITIDE TURNOVER AND M1 MRNA EXPRESSION 111
Studies on aging processes. 111
PRENATAL EXPOSURE TO ETHANOL CAUSES DIFFERENTIAL EFFECTS IN THE NERVE GROWTH FACTOR AND ITS RECEPTORS IN BASAL FOREBRAIN OF PREWEANING AND ADULT RATS 107
Microencephaly induces a long lasting change in B-50 phosphorylation in rats 98
Identification of Cxorf1, a novel intronless gene in Xq27.3, expressed in human hippocampus. DNA and Cell Biol. 17, 1009-1016, 1998. 95
Expression of neuronal acetylcholine nicotinic receptor α4 and β2 subunits during postnatal development of the rat brain 86
Increased secretion of the amino-terminal fragment of amyloid precursor protein in rat brain of animals characterized by a constitutive upregulation of protein kinase C. J. Neurochem. 68, 2523-2529, 1997 73
Interaction of thiocolchicoside with [3H]strychnine binding sites in rat spinal cord and brainstem. Eur. J. Pharmacol. 318, 201-204, 1996. 70
Totale 18.486
Categoria #
all - tutte 55.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.485


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202187 0 0 0 0 0 0 0 0 0 0 0 87
2021/2022881 75 62 110 151 15 38 34 48 65 49 13 221
2022/20231.301 137 69 21 148 168 306 0 82 180 55 98 37
2023/2024237 36 29 17 27 21 50 11 0 1 20 8 17
2024/20251.184 53 64 330 52 21 103 123 77 114 71 68 108
2025/20265.618 249 493 1.085 520 275 165 360 64 2.018 199 140 50
Totale 18.486